Cephalothin. Its in vitro antibacterial spectrum as studied in a diagnostic laboratory.
Of 655 bacterial strains isolated in a routine clinical diagnostic laboratory, 564 (86 per cent) were found sensitive to cephalothin by disk sensitivity test. However, the fraction of sensitive Gram-negative bacilli and enterococci declined sharply at concentrations approximating those obtained in serum after the usual recommended dosages. Gram-positive bacteria remained sensitive throughout the entire range of testing concentrations. Unless very high dosages are used, cephalothin cannot be considered a broad-spectrum antibacterial agent for use while cultures are pending. Even with very high dosages all strains of Pseudomonas spp. and significant fractions of other Gram-negative bacillary species remain resistant to cephalothin. If used alone, the high potency cephalothin disk may yield inadequate information and should be supplemented by a lower potency disk, standardized measurements of zone diameters, or a screening plate.
D002512:Cephalothin / Q000494:pharmacology*; D066298:In Vitro Techniques
D002512:Cephalothin
Stanford Med Bull. 1953 Aug;11(3):183-7
13102038
N Engl J Med. 1963 Nov 14;269:1074-82 CONTD
14085067
JAMA. 1964 Sep 14;189:823-8
14172279
Appl Microbiol. 1963 Mar;11:122-7
13963283
Am J Med Sci. 1964 Dec;248:640-56
14251901
JAMA. 1964 Sep 14;189:829-34
14172280
J Bacteriol. 1962 Dec;84:1292-6
13968796
Arch Intern Med. 1963 Jul;112:21-8
13988897